A detailed history of D. E. Shaw & Co., Inc. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 423,498 shares of PCVX stock, worth $36.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
423,498
Holding current value
$36.4 Million
% of portfolio
0.05%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$70.52 - $117.12 $13.6 Million - $22.6 Million
193,291 Added 83.96%
423,498 $48.4 Million
Q2 2024

Aug 14, 2024

SELL
$60.06 - $78.77 $8.23 Million - $10.8 Million
-137,042 Reduced 37.32%
230,207 $17.4 Million
Q1 2024

May 15, 2024

SELL
$59.79 - $81.05 $4.25 Million - $5.76 Million
-71,062 Reduced 16.21%
367,249 $25.1 Million
Q4 2023

Feb 14, 2024

SELL
$45.35 - $63.41 $4.54 Million - $6.35 Million
-100,073 Reduced 18.59%
438,311 $27.5 Million
Q3 2023

Nov 14, 2023

SELL
$46.0 - $53.1 $12.6 Million - $14.6 Million
-274,528 Reduced 33.77%
538,384 $27.4 Million
Q2 2023

Aug 14, 2023

BUY
$34.66 - $54.07 $624,053 - $973,530
18,005 Added 2.27%
812,912 $40.6 Million
Q1 2023

May 15, 2023

SELL
$36.27 - $47.2 $6.43 Million - $8.37 Million
-177,414 Reduced 18.25%
794,907 $29.8 Million
Q4 2022

Feb 14, 2023

BUY
$20.58 - $47.95 $20 Million - $46.6 Million
972,321 New
972,321 $46.6 Million

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $5.1B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.